Table 12: Selected Primary (Malignant
and Non-Malignant)
Brain and Central Nervous System Tumor Age-Specific
Incidence Ratesa by Age at Diagnosis,
CBTRUS 1995-1999b
Histology
|
Age at Diagnosis
|
||||||||
|
|
0-14 |
0-19 |
20-34 |
35-44 |
45-54 |
55-64 |
65-74 |
75-84 |
85+ |
|
|
|
|
|
|
|
|
|
|
|
Tumors of Neuroepithelial Tissue
|
3.29
|
3.07 |
3.47 |
4.70 |
7.67 |
12.97 |
18.99 |
18.26 |
9.53 |
|
Pilocytic
astrocytoma |
0.78 |
0.70 |
0.20 |
0.12 |
0.12 |
0.09 |
0.07 |
- |
- |
|
Diffuse
astrocytoma |
0.05 |
0.06 |
0.09 |
0.13 |
0.14 |
0.27 |
0.32 |
0.27 |
- |
|
Anaplastic
astrocytoma |
0.09 |
0.10 |
0.36 |
0.53 |
0.75 |
0.91 |
1.33 |
1.16 |
0.48 |
|
Unique
astrocytoma variants |
0.07 |
0.07 |
0.05 |
0.03 |
0.07 |
0.08 |
0.10 |
0.12 |
- |
|
Astrocytoma,
NOS |
0.30 |
0.29 |
0.47 |
0.55 |
0.64 |
0.77 |
1.23 |
1.55 |
0.78 |
|
Glioblastoma |
0.15 |
0.15 |
0.44 |
1.34 |
3.99 |
8.76 |
13.74 |
12.78 |
6.54 |
|
Oligodendroglioma |
0.07 |
0.09 |
0.50 |
0.68 |
0.58 |
0.48 |
0.37 |
0.32 |
- |
|
Anaplastic
oligodendroglioma |
0.02 |
0.03 |
0.16 |
0.22 |
0.26 |
0.29 |
0.23 |
0.16 |
- |
|
Ependymoma/anaplastic
ependymoma |
0.26 |
0.23 |
0.22 |
0.26 |
0.31 |
0.30 |
0.28 |
0.18 |
- |
|
Ependymoma
variants |
- |
0.02 |
0.08 |
0.07 |
0.08 |
0.08 |
- |
- |
- |
|
Mixed
glioma |
0.02 |
0.03 |
0.20 |
0.19 |
0.19 |
0.23 |
0.18 |
0.09 |
- |
|
Glioma
malignant, NOS |
0.39 |
0.35 |
0.21 |
0.23 |
0.25 |
0.39 |
0.85 |
1.34 |
1.24 |
|
Embryonal/primitive/ medulloblastoma |
0.74 |
0.63 |
0.21 |
0.12 |
0.09 |
0.05 |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
Tumors of Cranial and Spinal Nerves
|
0.06 |
0.08 |
0.56 |
1.14 |
1.95 |
2.61 |
2.44 |
1.47 |
0.70 |
|
Nerve
sheath, benign and malignant |
0.06 |
0.08 |
0.56 |
1.14 |
1.95 |
2.61 |
2.44 |
1.47 |
0.70 |
|
|
|
|
|
|
|
|
|
|
|
Tumors of the Meninges
|
0.12 |
0.17 |
0.90 |
2.82 |
5.15 |
8.18 |
13.12 |
17.23 |
19.05 |
|
Meningioma |
0.08 |
0.12 |
0.74 |
2.62 |
4.89 |
7.89 |
12.79 |
17.04 |
18.86 |
|
Hemangioblastoma |
- |
0.03 |
0.14 |
0.15 |
0.20 |
0.18 |
0.21 |
0.16 |
- |
|
|
|
|
|
|
|
|
|
|
|
Lymphomas and Hemopoietic Neoplasms
|
0.02 |
0.02 |
0.19 |
0.40 |
0.42 |
0.70 |
1.25 |
1.16 |
0.51 |
|
Lymphoma |
0.02 |
0.02 |
0.19 |
0.40 |
0.42 |
0.70 |
1.25 |
1.16 |
0.51 |
|
|
|
|
|
|
|
|
|
|
|
Germ Cell Tumors
|
0.14 |
0.17 |
0.09 |
- |
- |
- |
- |
- |
- |
|
Germ
cell |
0.14 |
0.17 |
0.09 |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
Tumors of the Sellar Region
|
0.16 |
0.25 |
0.91 |
1.09 |
1.49 |
1.96 |
2.08 |
1.69 |
1.21 |
|
Pituitary |
0.03 |
0.12 |
0.82 |
0.97 |
1.37 |
1.81 |
1.97 |
1.65 |
1.14 |
|
Craniopharyngioma |
0.14 |
0.13 |
0.09 |
0.12 |
0.11 |
0.15 |
0.11 |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
Local Extensions from Regional Tumors
|
- |
0.02 |
0.02 |
0.03 |
0.03 |
0.06 |
0.05 |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
Unclassified Tumors
|
0.15 |
0.15 |
0.25 |
0.36 |
0.48 |
0.92 |
1.79 |
3.68 |
7.49 |
|
|
|
|
|
|
|
|
|
|
|
Totalc
|
3.96
|
3.94 |
6.40 |
10.55 |
17.21 |
27.42 |
39.73 |
43.55 |
38.54 |
aRates are per 100,000 person-years.